Replies to post #2318 on Immunotech Laboratories Inc (IMMB)

[NanoEE]

With in your link are you citing IMMB is still suspended?

Item thirteen says different:

13
attach to its answering brief is granted. We have determined to resolve the petition without
The Division’s unopposed motion for leave to file exhibits that it inadvertently failed to
scheduling an in-person hearing. See Rule of Practice 550(b), 17 C.F.R. § 201.550(b) (stating (footnote continued . . . ) trading suspension is no longer in effect, we have the authority to resolve Immunotech’s petition on the merits.14 Among other things, our decision to address the substance of Immunotech’s arguments promotes the development of the record in the event Immunotech seeks judicial review.

The SEC filed the suspension citing the claim is misleading.

At that time the SEC had no clue about this company or it’s manufacturing of the ImmunH.

Which would make sense if you are a start up and you make a claim in regard of having a medicine that can fight Ebola head on, that would draw a lot of suspicion.

[Dodgeball]

$IMMB is not currently suspended. It trades on the Expert Market, so there is no publicly quoted Bid/Ask. Volume is low, and prices have been ranging from $0.01 to $0.04, making it difficult to determine a market value.

Harry needs to get the filings up to date. As of the last Annual Report filed, the company had $10,000,000 in intangible assets, 49% ownership in ImmunoTech BG. In the interim, they may have acquired shares in $ENZC. And IF any assets were transferred to $ENCZ we need to know what was paid for them. Otherwise they still belong to the $IMMB shareholders.